NASDAQ:AMBI AMBI (AMBI) Stock Price, News & Analysis → Gold Mania (From Stansberry Research) (Ad) Free AMBI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$4.11▼$4.5050-Day Range N/A52-Week Range N/AVolume5,529 shsAverage Volume4,504 shsMarket Capitalization$234.83 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsHeadlinesSocial MediaStock AnalysisCompetitorsHeadlinesSocial Media Get AMBI alerts: Email Address Ad Awesomely, LLCAutomatic Income (from home)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. Just click here now to watch my presentation for free. About AMBI Stock (NASDAQ:AMBI)Ambit Biosciences Corporation is a biopharmaceutical company. The Company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases. The Company’s lead drug candidate, quizartinib, is in Phase IIb clinical development in patients with relapsed/refractory acute myeloid leukemia (AML). The Company’s second drug candidate in clinical development, AC410, is a potent, selective, orally-administered, small molecule inhibitor of Janus kinase 2 (JAK2) that has potential utility for the treatment of autoimmune and inflammatory diseases. The Company’s third program consists of two selective small molecule compounds, AC708 and AC855, which inhibit the colony-stimulating factor-1 receptor (CSF1R), a receptor tyrosine kinase.Read More Ad Awesomely, LLCAutomatic Income (from home)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. Just click here now to watch my presentation for free. AMBI Stock News HeadlinesMay 1, 2024 | msn.comPolyamorous youth experience stigma and higher depressive symptomsMay 1, 2024 | axios.comAnoka's drinks to-go are back this summerMay 5, 2024 | Porter & Company (Ad)Elon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.May 1, 2024 | msn.comThis Twin Cities suburb is expanding its own spin on Bourbon StreetApril 30, 2024 | msn.comNSC Cooperative Society declares 60% net surplusApril 29, 2024 | msn.comStacey Dash Accused Of Trying To Be White Passing After Fans Noticed Whiter ComplexionApril 25, 2024 | msn.comAmbi Subramaniam and Kaushiki Chakraborty to Minnesotans: Lean in on Indian classical music, it's funApril 23, 2024 | finance.yahoo.comP&G Brands Help This Year's Prospects Be Ready for Anything Ahead of the 2024 NFL DraftMay 5, 2024 | Porter & Company (Ad)Elon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.April 23, 2024 | msn.comNetizens Elated After University Graduate Who Celebrated His Graduation with Bad Grammar ApologisesApril 22, 2024 | msn.comNine of Sydney’s best Indian eateries and restaurantsApril 20, 2024 | msn.comComposer Shantanu Moitra's Transformative 3,000 Km Journey Becomes A Captivating YouTube SeriesApril 16, 2024 | finance.yahoo.comP&G Appoints Neal Reed as Senior Vice President and Managing Director, P&G Australia and New ZealandApril 13, 2024 | msn.comMP: Minor Girl Abducted, Sold Off For ₹90K In Alirajpur; 3 BookedApril 12, 2024 | ca.news.yahoo.comThese 74 robotics companies are hiringApril 11, 2024 | msn.comJaanmoni ki Shaap, Jinto-Gabri's dirty game to Mohanlal's swag: Bigg Boss Malayalam 6 Week 4 reviewApril 9, 2024 | msn.comEast Bay EDA Honors Two Alameda Businesses for InnovationApril 8, 2024 | msn.comAmbidextrous San Diego man shares the benefits of 'Symmetrical Living'April 4, 2024 | msn.comBambi: The Reckoning teaser is stuff children's horror dreams are made ofApril 3, 2024 | au.finance.yahoo.comTide evo, a Revolutionary New Tile Form a Decade in the Making, is Now Available Exclusively in ColoradoApril 3, 2024 | msn.comWB projects only 1.8 percent growth for PakistanMarch 29, 2024 | sg.style.yahoo.comSandy Wu's cafe attacked by two menMarch 29, 2024 | msn.comTaiwanese Star Sandy Wu’s Cafe Targeted With Vandalism AttackMarch 25, 2024 | msn.comHollywood And Fans Are Already Buzzing Over Christopher Nolan's Next FilmMarch 22, 2024 | msn.comHow Hallmark Favorite Tyler Hynes Is Celebrating Women — and His Mom! — with New Movie “Shifting Gears” (Exclusive)March 21, 2024 | cbsnews.comBusinesswomen connect and share secrets to success in HarlemMarch 21, 2024 | msn.comFeel Like You Can Be Both Poly *and* Monogamous? You Might Be AmbiamorousSee More Headlines Receive AMBI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AMBI and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/06/2014Today5/05/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorIndustrial Products Industry Sanitary services Sub-IndustryN/A Current SymbolNASDAQ:AMBI CUSIPN/A CIK1131543 Webwww.hpxcorp.com Phone+1-858-3342100FaxN/AEmployees5,041Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio1.33 Current Ratio2.29 Quick Ratio2.23 Sales & Book Value Annual Sales$326.33 million Price / Sales0.72 Cash Flow$6.14 per share Price / Cash Flow0.69 Book Value$10.21 per share Price / Book0.42Miscellaneous Outstanding Shares55,410,000Free Float46,544,000Market Cap$234.83 million OptionableNot Optionable Beta0.69 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key CompetitorsPerma-Fix Environmental ServicesNASDAQ:PESIQuad/GraphicsNYSE:QUADiRobotNASDAQ:IRBTTwin DiscNASDAQ:TWINLuxferNYSE:LXFRView All Competitors AMBI Stock Analysis - Frequently Asked Questions How were AMBI's earnings last quarter? AMBI (NASDAQ:AMBI) announced its quarterly earnings data on Tuesday, May, 6th. The biopharmaceutical company reported ($0.50) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.47) by $0.03. The biopharmaceutical company earned $0.03 million during the quarter, compared to analyst estimates of $3.50 million. What other stocks do shareholders of AMBI own? Based on aggregate information from My MarketBeat watchlists, some companies that other AMBI investors own include Alexion Pharmaceuticals (ALXN), Amarin (AMRN), Broadcom (BRCM), Cytokinetics (CYTK), Delta Air Lines (DAL), Fortress Biotech (FBIO), FireEye (FEYE), Five Prime Therapeutics (FPRX), Glu Mobile (GLUU) and Halozyme Therapeutics (HALO). This page (NASDAQ:AMBI) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldCharles Payne Demystifies OptionsUnstoppable ProsperityThe asset beating inflation by 4xColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AMBI Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
